1. MALAT1 rs619586 polymorphism functions as a prognostic biomarker in the management of differentiated thyroid carcinoma
   Meng‐li Wang et al, 2019, J Cell Physiol CrossRef
2. Single-Cell Analysis Reveals a Preexisting Drug-Resistant Subpopulation in the Luminal Breast Cancer Subtype
   Marta Prieto-Vila et al, 2019, Cancer Res CrossRef
3. WNT10A induces apoptosis of senescent synovial resident stem cells through WNT/calcium pathway-mediated HDAC5 phosphorylation in OA joints
   Xu Cao et al, 2021, Bone CrossRef
4. Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway
   Chakit Arora et al, 2021, PLoS ONE CrossRef
5. Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines
   Francesca Maria Orlandella et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
6. Clinical importance of PLA2R1 and RASSF9 in thyroid cancer and their inhibitory roles on the Wnt/β-catenin pathway and thyroid cancer cell malignant behaviors
   Qiu Xu et al, 2022, Pathology - Research and Practice CrossRef
7. Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer
   Jing Li et al, 2022, Front. Endocrinol. CrossRef
8. Natural compounds as a potential modifier of stem cells renewal: Comparative analysis
   Amaresh Mishra et al, 2022, European Journal of Pharmacology CrossRef
9. Enhanced expression of Cyclin D1 and C-myc, a prognostic factor and possible mechanism for recurrence of papillary thyroid carcinoma
   Mojgan Sanjari et al, 2020, Sci Rep CrossRef
10. Prediction of the invasiveness of PTMC by a combination of ultrasound and the WNT10A gene
    Zhang Yan et al, 2022, Front. Endocrinol. CrossRef
11. Clinical and Pathological Features and Gene Expression Profiles of Clinically Aggressive Papillary Thyroid Carcinomas
    Jasna Metovic et al, 2023, Endocr Pathol CrossRef